BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33406870)

  • 1. Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death After Reperfusion Therapy in Acute Ischemic Stroke Patients.
    Zhang X; Yan S; Zhong W; Yu Y; Lou M
    Stroke; 2021 Jan; 52(2):537-542. PubMed ID: 33406870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated NT-proBNP predicts unfavorable outcomes in patients with acute ischemic stroke after thrombolytic therapy.
    Zhu Z; Muhammad B; Du B; Gu N; Meng TY; Kan S; Mu YF; Cheng YB; Zhu SG; Geng DQ
    BMC Neurol; 2023 May; 23(1):203. PubMed ID: 37221489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke.
    Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D
    Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
    BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the B-type Natriuretic Peptide before thrombolysis and prognosis in patients with ischemic stroke.
    Pan H; Feng K; Fu M; Ge W; Zhou C
    Clin Neurol Neurosurg; 2021 Dec; 211():107021. PubMed ID: 34808477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of NT-proBNP After Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Cohort Studies.
    Zhao YH; Gao H; Pan ZY; Li J; Huang WH; Wang ZF; Li ZQ
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104659. PubMed ID: 32067852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke.
    García-Carmona JA; Conesa-García E; Vidal-Mena D; González-Morales M; Ramos-Arenas V; Sánchez-Vizcaíno-Buendía C; Soria-Torrecillas JJ; Pérez-Vicente JA; García-de-Guadiana-Romualdo L
    Neurologia (Engl Ed); 2024; 39(6):496-504. PubMed ID: 38901926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
    Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
    J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome.
    Bajwa EK; Januzzi JL; Gong MN; Thompson BT; Christiani DC
    Crit Care Med; 2008 Aug; 36(8):2322-7. PubMed ID: 18596623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
    Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
    Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
    Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
    Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke.
    Jensen JK; Mickley H; Bak S; Korsholm L; Kristensen SR
    Cerebrovasc Dis; 2006; 22(5-6):439-44. PubMed ID: 16912478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
    Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
    Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
    Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
    Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.